GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sailong Pharmaceutical Group Co Ltd (SZSE:002898) » Definitions » Operating Margin %

Sailong Pharmaceutical Group Co (SZSE:002898) Operating Margin % : 2.20% (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Sailong Pharmaceutical Group Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Sailong Pharmaceutical Group Co's Operating Income for the three months ended in Mar. 2025 was ¥1.2 Mil. Sailong Pharmaceutical Group Co's Revenue for the three months ended in Mar. 2025 was ¥54.1 Mil. Therefore, Sailong Pharmaceutical Group Co's Operating Margin % for the quarter that ended in Mar. 2025 was 2.20%.

The historical rank and industry rank for Sailong Pharmaceutical Group Co's Operating Margin % or its related term are showing as below:

SZSE:002898' s Operating Margin % Range Over the Past 10 Years
Min: -60.95   Med: 7.5   Max: 29.1
Current: -4.7


SZSE:002898's Operating Margin % is ranked better than
71.67% of 992 companies
in the Biotechnology industry
Industry Median: -126.37 vs SZSE:002898: -4.70

Sailong Pharmaceutical Group Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Sailong Pharmaceutical Group Co's Operating Income for the three months ended in Mar. 2025 was ¥1.2 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-11.7 Mil.


Sailong Pharmaceutical Group Co Operating Margin % Historical Data

The historical data trend for Sailong Pharmaceutical Group Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sailong Pharmaceutical Group Co Operating Margin % Chart

Sailong Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -60.95 -6.74 -9.90 3.75 -2.90

Sailong Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.49 4.48 -7.20 -27.28 2.20

Competitive Comparison of Sailong Pharmaceutical Group Co's Operating Margin %

For the Biotechnology subindustry, Sailong Pharmaceutical Group Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sailong Pharmaceutical Group Co's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sailong Pharmaceutical Group Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Sailong Pharmaceutical Group Co's Operating Margin % falls into.


;
;

Sailong Pharmaceutical Group Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Sailong Pharmaceutical Group Co's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=-7.653 / 263.567
=-2.90 %

Sailong Pharmaceutical Group Co's Operating Margin % for the quarter that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=1.189 / 54.087
=2.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sailong Pharmaceutical Group Co  (SZSE:002898) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Sailong Pharmaceutical Group Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of Sailong Pharmaceutical Group Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sailong Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 47, Haibin South Road, 2nd Floor, Everbright International Trade Center, Guangdong Province, Zhuhai, CHN, 519015
Sailong Pharmaceutical Group Co Ltd is a pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.
Executives
Tang Lin Director
Long Zhi Xiang Director
Deng Yong Jun Supervisors
Zhou Bei Supervisors
Li Jian Feng Directors, executives

Sailong Pharmaceutical Group Co Headlines

No Headlines